↓ Skip to main content

Clinical Activity, Tolerability, and Long-Term Follow-Up of Durvalumab in Patients With Advanced NSCLC

Overview of attention for article published in Journal of Thoracic Oncology, June 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

news
1 news outlet
twitter
1 X user
reddit
1 Redditor
guideline
1 clinical guideline source

Readers on

mendeley
90 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 90 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 90 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Other 11 12%
Student > Bachelor 9 10%
Researcher 8 9%
Professor 5 6%
Student > Postgraduate 5 6%
Other 16 18%
Unknown 36 40%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 29 32%
Biochemistry, Genetics and Molecular Biology 7 8%
Nursing and Health Professions 6 7%
Immunology and Microbiology 2 2%
Engineering 2 2%
Other 6 7%
Unknown 38 42%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 April 2024.
All research outputs
#3,429,821
of 32,375,021 outputs
Outputs from Journal of Thoracic Oncology
#675
of 4,207 outputs
Outputs of similar age
#56,217
of 388,072 outputs
Outputs of similar age from Journal of Thoracic Oncology
#17
of 50 outputs
Altmetric has tracked 32,375,021 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,207 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.7. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 388,072 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 50 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.